SEC Tracker
Get the app

Corcept Therapeutics CORT

David L Mahoney (Director) plans to sell 10,000 CORT shares, about $308,700

Form
144/A
Filed
Importance
Routine
Document
Form 144/A
  1. Approximate sale date: Aug 14, 2023
  2. Broker: Charles Schwab Corporation
  3. Shares acquired by: Stock Option Exercise

All of David L Mahoney's insider filings, holdings and planned sales

Written from the Form 144/A on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Corcept Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Repligen RGEN public float $6.0B, Jun 30, 2025
  2. Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
  3. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025
  4. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  5. Revolution Medicines RVMD public float $6.7B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.